Income Statement (TTM)
West Pharmaceutical Services, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,037 | 2,147 | 2,326 | 2,522 | 2,681 | 2,832 | 2,881 | 2,929 | 2,909 | 2,887 | 2,884 | 2,866 | 2,926 | 2,950 | 2,929 | 2,877 | 2,876 | 2,893 | 2,896 | 2,960 |
| Change (%) | 5.38 | 8.35 | 8.44 | 6.28 | 5.62 | 1.74 | 1.66 | -0.67 | -0.76 | -0.12 | -0.61 | 2.11 | 0.80 | -0.72 | -1.77 | -0.02 | 0.58 | 0.09 | 2.22 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1,327 | 1,379 | 1,453 | 1,530 | 1,595 | 1,654 | 1,690 | 1,732 | 1,732 | 1,751 | 1,761 | 1,772 | 1,812 | 1,820 | 1,840 | 1,850 | 1,873 | 1,895 | 1,896 | 1,916 |
| Change (%) | 3.89 | 5.39 | 5.26 | 4.24 | 3.71 | 2.21 | 2.44 | 0.03 | 1.06 | 0.57 | 0.66 | 2.27 | 0.40 | 1.09 | 0.58 | 1.25 | 1.14 | 0.05 | 1.08 | |
| % of Revenue | 65.15 | 64.24 | 62.48 | 60.65 | 59.48 | 58.41 | 58.68 | 59.13 | 59.55 | 60.64 | 61.06 | 61.84 | 61.93 | 61.69 | 62.82 | 64.32 | 65.13 | 65.49 | 65.46 | 64.73 |
| Gross Operating Profit | 710 | 768 | 873 | 993 | 1,086 | 1,178 | 1,190 | 1,197 | 1,177 | 1,136 | 1,123 | 1,094 | 1,114 | 1,130 | 1,089 | 1,027 | 1,003 | 998 | 1,000 | 1,044 |
| Change (%) | 8.16 | 13.66 | 13.75 | 9.43 | 8.41 | 1.08 | 0.54 | -1.69 | -3.43 | -1.17 | -2.60 | 1.86 | 1.44 | -3.64 | -5.72 | -2.30 | -0.45 | 0.17 | 4.39 | |
| % of Revenue | 34.85 | 35.76 | 37.52 | 39.35 | 40.52 | 41.59 | 41.32 | 40.87 | 40.45 | 39.36 | 38.94 | 38.16 | 38.07 | 38.31 | 37.18 | 35.68 | 34.87 | 34.51 | 34.54 | 35.27 |
| SG&A | 291 | 301 | 308 | 310 | 340 | 356 | 362 | 352 | 377 | 316 | 319 | 326 | 299 | 354 | 355 | 349 | 342 | 335 | 335 | 346 |
| Change (%) | 3.37 | 2.36 | 0.58 | 9.75 | 4.82 | 1.68 | -2.79 | 7.10 | -16.22 | 0.82 | 2.23 | -8.17 | 18.39 | 0.20 | -1.52 | -2.03 | -2.16 | -0.03 | 3.43 | |
| % of Revenue | 14.28 | 14.01 | 13.24 | 12.28 | 12.68 | 12.58 | 12.58 | 12.03 | 12.97 | 10.95 | 11.05 | 11.36 | 10.22 | 12.00 | 12.12 | 12.15 | 11.90 | 11.58 | 11.56 | 11.70 |
| R&D | 44 | 47 | 48 | 51 | 52 | 53 | 55 | 56 | 56 | 58 | 61 | 63 | 66 | 68 | 69 | 70 | 69 | 69 | 68 | 69 |
| Change (%) | 6.11 | 3.20 | 6.20 | 1.17 | 1.54 | 4.55 | 1.09 | 0.90 | 3.91 | 4.27 | 3.44 | 4.44 | 3.79 | 0.73 | 1.45 | -1.29 | 0.14 | -1.88 | 2.36 | |
| % of Revenue | 2.17 | 2.18 | 2.08 | 2.04 | 1.94 | 1.86 | 1.92 | 1.91 | 1.94 | 2.03 | 2.12 | 2.20 | 2.25 | 2.32 | 2.35 | 2.43 | 2.40 | 2.39 | 2.34 | 2.34 |
| OpEx | 1,661 | 1,724 | 1,810 | 1,892 | 1,988 | 2,063 | 2,105 | 2,137 | 2,164 | 2,123 | 2,141 | 2,163 | 2,178 | 2,244 | 2,265 | 2,270 | 2,287 | 2,300 | 2,299 | 2,333 |
| Change (%) | 3.80 | 4.96 | 4.55 | 5.07 | 3.76 | 2.05 | 1.50 | 1.28 | -1.90 | 0.86 | 1.01 | 0.68 | 3.03 | 0.94 | 0.26 | 0.71 | 0.57 | -0.02 | 1.47 | |
| % of Revenue | 81.53 | 80.32 | 77.81 | 75.02 | 74.16 | 72.86 | 73.07 | 72.96 | 74.40 | 73.54 | 74.26 | 75.47 | 74.41 | 76.06 | 77.33 | 78.92 | 79.50 | 79.48 | 79.39 | 78.81 |
| Operating Income | 376 | 423 | 516 | 630 | 693 | 769 | 776 | 792 | 745 | 764 | 742 | 703 | 749 | 706 | 664 | 606 | 590 | 594 | 597 | 627 |
| Change (%) | 12.33 | 22.15 | 22.08 | 9.93 | 10.94 | 0.92 | 2.08 | -5.94 | 2.55 | -2.83 | -5.27 | 6.50 | -5.69 | -5.98 | -8.67 | -2.74 | 0.64 | 0.52 | 5.11 | |
| % of Revenue | 18.47 | 19.68 | 22.19 | 24.98 | 25.84 | 27.14 | 26.93 | 27.04 | 25.60 | 26.46 | 25.74 | 24.53 | 25.59 | 23.94 | 22.67 | 21.08 | 20.50 | 20.52 | 20.61 | 21.19 |
| Interest Expense | -8 | -8 | -8 | -8 | -8 | -8 | -8 | -8 | -9 | -8 | -8 | -9 | -10 | -9 | -8 | -7 | -5 | -3 | -2 | -0 |
| Change (%) | -0.00 | -1.22 | -1.23 | -3.75 | 6.49 | 3.66 | -1.18 | 4.76 | -10.23 | -0.00 | 11.39 | 7.95 | -5.26 | -6.67 | -14.29 | -30.56 | -40.00 | -40.00 | -77.78 | |
| % of Revenue | -0.40 | -0.38 | -0.35 | -0.32 | -0.29 | -0.29 | -0.30 | -0.29 | -0.30 | -0.27 | -0.27 | -0.31 | -0.32 | -0.31 | -0.29 | -0.25 | -0.17 | -0.10 | -0.06 | -0.01 |
| Net Income | 312 | 346 | 423 | 519 | 612 | 662 | 684 | 686 | 631 | 586 | 552 | 519 | 559 | 593 | 569 | 525 | 500 | 493 | 467 | 488 |
| Change (%) | 11.07 | 22.21 | 22.71 | 17.97 | 8.05 | 3.41 | 0.18 | -8.02 | -7.09 | -5.77 | -6.05 | 7.85 | 6.08 | -4.16 | -7.70 | -4.82 | -1.38 | -5.18 | 4.39 | |
| % of Revenue | 15.30 | 16.13 | 18.19 | 20.58 | 22.85 | 23.37 | 23.76 | 23.41 | 21.68 | 20.30 | 19.15 | 18.10 | 19.11 | 20.12 | 19.42 | 18.25 | 17.37 | 17.03 | 16.13 | 16.48 |
Source: Capital IQ
